$200M Singapore plant will be Amgen's first in Asia

01/18/2013 | Reuters

Amgen plans to invest about $200 million to construct a manufacturing plant at the Tuas Biomedical Park in Singapore. Work on the facility, Amgen's first in Asia, is expected to start within months. The plant's first products will be antibody drugs.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ